Exploring the Oculomotor Effects of Sustained-Release Fampridine in Multiple Sclerosis Patients with Gait Impairment. (.pdf)

Update Item Information
Identifier 20160301_nanos_posters_204
Title Exploring the Oculomotor Effects of Sustained-Release Fampridine in Multiple Sclerosis Patients with Gait Impairment. (.pdf)
Creator Cristina Duque; Jose Coelho; Joana Marcal; Isabel Ribeiro; Alda Melo; Carla Nunes; Carmo Macario; Sonia Batista; Livia Abreu; Joao Lemos
Affiliation (CD) Neurology Department, Coimbra University Hospital Center, Coimbra, Portugal
Subject Aminopyridines; Downbeat Nystagmus; Multiple Sclerosis; Internuclear Ophthalmoplegia; Video-Head Impulse Test
Description Fampridine is a potassium channel blocker that has been shown to suppress downbeat nystagmus effectively. Its effect upon other eye movement abnormalities is largely unknown. We sought to evaluate the immediate and late effects of sustained-release fampridine 10 mg twice a day upon eye movement abnormalities in MS patients with gait impairment and to ascertain the utility of fampridine's oculomotor response in predicting gait response.
Date 2016-03-01
Language eng
Format application/pdf
Type Text
Source 2016 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2016: Poster Presentations
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2016. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6wq39q3
Setname ehsl_novel_nam
ID 185293
Reference URL https://collections.lib.utah.edu/ark:/87278/s6wq39q3